Washington: A universal flu vaccine targeting a protein common to all strains of influenza A has safely produced an immune response in humans. If proven effective, the vaccine could eliminate the practice of creating a new flu vaccine annually to match predicted strains, with major implications for global health.
The technology used to produce the candidate vaccine would eliminate many of the limitations of current flu vaccines, including limited production capability and the inability to change the target antigen should the vaccine not match the circulating strains."As we saw in the 2009 influenza pandemic, there is a great public and global health need for a rapid, scalable model for vaccine production," said lead author Christine B. Turley, paediatrician and member of UTMB`s Sealy Centre for Vaccine Development. "If ultimately proven effective, VAX102 will meet this need and offer a completely new approach to global flu prevention and control." IANS
`Malaysia Airlines jet`s transponder deliberately switched off`
BJP denies Narendra Modi holding fund-raising dinner
US visa fraud: `Devyani`s re-indictment an act of aggression`
AAP releases LS candidates` list, Shazia Ilmi gets Ghaziabad ticket